Ebola Vaccines and Antivirals: What Lies Ahead?
603 views · Published 17 December 2014 · 1:51:33 · Indexed 8 November 2026
Channel: Center for Strategic & International Studies · 2014 · Education
There are rapidly accelerating efforts underway by industry, governments, NGOS, international organizations, and foundations to bring forward Ebola vaccines and antivirals. There have been promising early returns, amidst considerable unknowns and acute pressures to find safe, effective, and affordable new technological tools. Ambitious field trials are set to begin in the new year in West Africa. Hear what lies ahead from those on the front lines: Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Disease (NIAID) Dr. Moncef Slaoui, Member of the GSK Board of Directors and the Corporate Executive Team Dr. Johan Van Hoof, Global Therapeutic Area Head, Infectious Diseases and Vaccines, Janssen Research & Development, LLC Mr. Rohit Malpani, Director of Policy and Analysis, Medecins Sans Frontieres Access Campaign Dr. Julie Gerberding, President, Merck Vaccines Dr. J. Stephen Morrison, Senior Vice President and Director of the CSIS Global Health Policy Center will moderate. Programs Africa and Global Health, Global Health Policy Center Topics Global Health Regions Africa
More from this channel
-
3:22
Interviews: Surin Pitsuwan, Secretary General of ASEAN
-
2:34
Video Highlight: Anthony Fauci
-
2:00
Video Highlight: The Northern Distribution Network
-
2:45
Video Highlight: Assessing the Terrorist Threat
-
2:51
Video Highlight: "Stimulus Works"
-
3:54
Video Highlight: Schieffer Series: Public Diplomacy in the D
-
4:51
Video Highlights: Keith B. Alexander on Cybersecurity
-
1:21
What is the Schieffer Series